ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
特应性皮炎:皮肤和免疫对减少过敏原暴露的反应
基本信息
- 批准号:8167150
- 负责人:
- 金额:$ 0.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-03-01 至 2013-02-28
- 项目状态:已结题
- 来源:
- 关键词:AllergensAllergicAntibodiesAtopic DermatitisB-LymphocytesCell surfaceClinicalComputer Retrieval of Information on Scientific Projects DatabaseDataDiscriminant AnalysisDiseaseEnvironmentFelis catusFlow CytometryFundingGrantHospitalsIgEImmuneImmune responseImmunoglobulin GIn VitroIndividualInstitutionLesionLinear RegressionsMeasurementMonitorPatientsPeptidesProductionPyroglyphidaeRegimenRegression AnalysisReportingResearchResearch PersonnelResourcesSerumSkinSourceStudentsT cell responseT-LymphocyteT-Lymphocyte SubsetsTestingTimeUnited States National Institutes of Healthcytokine
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Elevated total IgE and specific IgE to allergens from diverse sources including cat and house dust mite (HDM) have been demonstrated in patients with atopic dermatitis (AD). Improvement of eczematous lesions has been reported when patients are admitted to the hospital, which represents an "allergen-free" environment. Severe clinical disease in AD patients has been attributed to suppression of the immune response or immune dysregulation. We have recently demonstrated that the immune response to allergens is altered at both the B-cell and T-cell level in allergic patients with AD. We will test the hypothesis that allergen avoidance in subjects with IgE ab to common allergens is associated with improvement of skin condition and changes in the immune response to allergens derived from HDM and cat. Serum antibodies (IgG and IgE) and T cell responses to common allergens and allergen-derived peptides will be monitored at weekly intervals (3 weeks maximum) in AD patients who receive a complete allergen avoidance regimen in a hospital environment. Detailed analysis of in vitro T cell responses will include measurement of allergen-stimulated proliferation and cytokine production, expression of cell surface markers by flow cytometry and enumeration of different T cell subsets. Data will be compared at each time point within each individual in order to determine changes which occur during allergen avoidance. Results will also be compared between groups of AD patients with and without IgE ab to common allergens. Statisical tests will include student's t test, cross-validated linear discriminant analysis, and linear regression analysis.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目及
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
特应性皮炎 (AD) 患者的总 IgE 和特异性 IgE 升高,这些过敏原来自不同来源,包括猫和屋尘螨 (HDM)。 据报道,患者入院时湿疹皮损有所改善,这代表了“无过敏原”的环境。 AD 患者的严重临床疾病归因于免疫反应抑制或免疫失调。 我们最近证明,过敏性 AD 患者的 B 细胞和 T 细胞水平对过敏原的免疫反应都发生了改变。 我们将检验以下假设:具有常见过敏原 IgE ab 的受试者回避过敏原与皮肤状况的改善以及对 HDM 和猫过敏原的免疫反应的变化有关。 对于在医院环境中接受完整过敏原避免方案的 AD 患者,将每周(最多 3 周)监测血清抗体(IgG 和 IgE)和 T 细胞对常见过敏原和过敏原衍生肽的反应。 体外 T 细胞反应的详细分析将包括测量过敏原刺激的增殖和细胞因子的产生、通过流式细胞术测量细胞表面标记物的表达以及不同 T 细胞亚群的计数。 将比较每个人每个时间点的数据,以确定避免过敏原期间发生的变化。 还将对具有和不具有常见过敏原 IgE 抗体的 AD 患者组之间的结果进行比较。 统计检验将包括学生 t 检验、交叉验证的线性判别分析和线性回归分析。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Judith A Woodfolk其他文献
Use of a novel air cleaner to monitor airborne allergen
- DOI:
10.1016/s0091-6749(02)81248-9 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Natalie J Custis;Judith A Woodfolk;John W Vaughan;Thomas AE Platts-Mills - 通讯作者:
Thomas AE Platts-Mills
Judith A Woodfolk的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Judith A Woodfolk', 18)}}的其他基金
Immune Programs and Related T Cell Mechanisms of Pulmonary Complications After COVID-19 Illness
COVID-19 疾病后肺部并发症的免疫程序和相关 T 细胞机制
- 批准号:
10886167 - 财政年份:2023
- 资助金额:
$ 0.94万 - 项目类别:
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and Disease
健康和疾病中对 SARS-CoV-2 做出反应的保护性和致病性 T 细胞
- 批准号:
10218954 - 财政年份:2021
- 资助金额:
$ 0.94万 - 项目类别:
Protective and Pathogenic T Cells Responding to SARS-CoV-2 in Health and Disease
健康和疾病中对 SARS-CoV-2 做出反应的保护性和致病性 T 细胞
- 批准号:
10488185 - 财政年份:2021
- 资助金额:
$ 0.94万 - 项目类别:
Regulation of TSLP receptor expression and function in eczema in mice and man
小鼠和人湿疹中 TSLP 受体表达和功能的调节
- 批准号:
8651423 - 财政年份:2011
- 资助金额:
$ 0.94万 - 项目类别:
Regulation of TSLP receptor expression and function in eczema in mice and man
小鼠和人湿疹中 TSLP 受体表达和功能的调节
- 批准号:
8106840 - 财政年份:2011
- 资助金额:
$ 0.94万 - 项目类别:
Regulation of TSLP receptor expression and function in eczema in mice and man
小鼠和人湿疹中 TSLP 受体表达和功能的调节
- 批准号:
8460063 - 财政年份:2011
- 资助金额:
$ 0.94万 - 项目类别:
Regulation of TSLP receptor expression and function in eczema in mice and man
小鼠和人湿疹中 TSLP 受体表达和功能的调节
- 批准号:
8244445 - 财政年份:2011
- 资助金额:
$ 0.94万 - 项目类别:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
特应性皮炎:皮肤和免疫对减少过敏原暴露的反应
- 批准号:
7951462 - 财政年份:2009
- 资助金额:
$ 0.94万 - 项目类别:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
特应性皮炎:皮肤和免疫对减少过敏原暴露的反应
- 批准号:
7718542 - 财政年份:2008
- 资助金额:
$ 0.94万 - 项目类别:
ATOPIC DERMATITIS: SKIN AND IMMUNE RESPONSE TO REDUCED ALLERGEN EXPOSURE
特应性皮炎:皮肤和免疫对减少过敏原暴露的反应
- 批准号:
7606686 - 财政年份:2007
- 资助金额:
$ 0.94万 - 项目类别:
相似海外基金
Development of therapeutic monoclonal antibodies aiming at an application and the immunosuppression to an allergic disease of Fingolimod
针对芬戈莫德过敏性疾病的应用和免疫抑制的治疗性单克隆抗体的开发
- 批准号:
16K08409 - 财政年份:2016
- 资助金额:
$ 0.94万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prevention of Allergic Rhinitis with Topical Immunomodulating Antibodies
使用外用免疫调节抗体预防过敏性鼻炎
- 批准号:
8201881 - 财政年份:2011
- 资助金额:
$ 0.94万 - 项目类别:
Development of antibodies to Il-13 receptor and their preclinical testing in a sheep model for human allergic asthma
IL-13受体抗体的开发及其在人类过敏性哮喘绵羊模型中的临床前测试
- 批准号:
nhmrc : 310603 - 财政年份:2004
- 资助金额:
$ 0.94万 - 项目类别:
Early Career Fellowships
B-1 B cells as a source of polyreactive IgE antibodies, in allergic individuals
B-1 B 细胞作为过敏个体中多反应性 IgE 抗体的来源
- 批准号:
nhmrc : 209590 - 财政年份:2002
- 资助金额:
$ 0.94万 - 项目类别:
NHMRC Project Grants
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
- 批准号:
10518418 - 财政年份:1984
- 资助金额:
$ 0.94万 - 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
- 批准号:
10119751 - 财政年份:1984
- 资助金额:
$ 0.94万 - 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
- 批准号:
10425338 - 财政年份:1984
- 资助金额:
$ 0.94万 - 项目类别:
IgE antibodies to the mammalian oligosaccharide galactose-alpha-1, 3-galactose (alpha-gal): immunology, epidemiology and relevance to allergic and inflammatory disease
哺乳动物寡糖半乳糖-α-1, 3-半乳糖 (α-gal) 的 IgE 抗体:免疫学、流行病学以及与过敏性和炎症性疾病的相关性
- 批准号:
10190780 - 财政年份:1984
- 资助金额:
$ 0.94万 - 项目类别:














{{item.name}}会员




